Cargando…

Vitreous protein networks around ANG2 and VEGF in proliferative diabetic retinopathy and the differential effects of aflibercept versus bevacizumab pre-treatment

Extracellular signalling proteins interact in networks rather than in isolation. In this context we investigated vitreous protein levels, including placental growth factor (PlGF), angiopoietin-2 (ANG2) and vascular endothelial growth factor (VEGF), in patients with proliferative diabetic retinopathy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klaassen, Ingeborg, Avery, Peter, Schlingemann, Reinier O., Steel, David H. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726866/ https://www.ncbi.nlm.nih.gov/pubmed/36473885 http://dx.doi.org/10.1038/s41598-022-25216-z

Ejemplares similares

microRNA Expression Profile in the Vitreous of Proliferative Diabetic Retinopathy Patients and Differences from Patients Treated with Anti-VEGF Therapy
por: Friedrich, Julian, et al.
Publicado: (2020)

Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes
por: Klaassen, Ingeborg, et al.
Publicado: (2017)

The Angio-Fibrotic Switch of VEGF and CTGF in Proliferative Diabetic Retinopathy
por: Kuiper, Esther J., et al.
Publicado: (2008)

Infographic: intravitreous aflibercept vs vitrectomy with panretinal photocoagulation for vitreous haemorrhage from proliferative diabetic retinopathy
por: Song, Anna, et al.
Publicado: (2021)

A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy
por: Van Geest, Rob J, et al.
Publicado: (2012)

Intravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathy
por: El-Batarny, Ashraf M
Publicado: (2007)

Early Vitreous Hemorrhage after Vitrectomy with Preoperative Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
por: Sato, Tatsuhiko, et al.
Publicado: (2013)

The Aflibercept-Induced MicroRNA Profile in the Vitreous of Proliferative Diabetic Retinopathy Patients Detected by Next-Generation Sequencing
por: Guo, Ju, et al.
Publicado: (2021)

Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients
por: Izuta, Hiroshi, et al.
Publicado: (2009)

VEGF-Independent Activation of Müller Cells by the Vitreous from Proliferative Diabetic Retinopathy Patients
por: Rezzola, Sara, et al.
Publicado: (2021)

Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy
por: Wirkkala, Joonas, et al.
Publicado: (2019)

miRNA Levels as a Biomarker for Anti-VEGF Response in Patients with Diabetic Macular Edema
por: Vader, Maartje J. C., et al.
Publicado: (2021)

Proliferative diabetic retinopathy and relations among antioxidant activity, oxidative stress, and VEGF in the vitreous body
por: Izuta, Hiroshi, et al.
Publicado: (2010)

Vitreous and Plasma VEGF Levels as Predictive Factors in the Progression of Proliferative Diabetic Retinopathy after Vitrectomy
por: Wang, Jiaxing, et al.
Publicado: (2014)

Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy
por: Chernykh, VV, et al.
Publicado: (2015)

Characterisation of the vitreous proteome in proliferative diabetic retinopathy
por: Wang, Hao, et al.
Publicado: (2012)

Postvitrectomy diabetic vitreous hemorrhage in proliferative diabetic retinopathy
por: Shi, Lei, et al.
Publicado: (2012)

Complement Activation in the Vitreous of Patients With Proliferative Diabetic Retinopathy
por: Mandava, Nikhil, et al.
Publicado: (2020)

Plasma and Vitreous Metabolomics Profiling of Proliferative Diabetic Retinopathy
por: Wang, Hanying, et al.
Publicado: (2022)

Cytokine Levels in Human Vitreous in Proliferative Diabetic Retinopathy
por: Loporchio, Dean F., et al.
Publicado: (2021)

Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity
por: Riazi-esfahani, Hamid, et al.
Publicado: (2021)

Effect of intravitreal conbercept injection on VEGF-A and -B levels in the aqueous and vitreous humor of patients with proliferative diabetic retinopathy
por: Zhang, Yunda, et al.
Publicado: (2021)

Identification of Chemokines and Growth Factors in Proliferative Diabetic Retinopathy Vitreous
por: Dai, Ying, et al.
Publicado: (2014)

Eicosanoid Profiles in the Vitreous Humor of Patients with Proliferative Diabetic Retinopathy
por: Lin, Albert L, et al.
Publicado: (2020)

The adjunctive use of pre-operative intravitreal bevacizumab in the setting of proliferative diabetic retinopathy
por: Al-Kharashi, Abdullah, et al.
Publicado: (2016)

Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy
por: Nicholson, Luke, et al.
Publicado: (2018)

Intravitreal bevacizumab prior to vitrectomy for proliferative diabetic retinopathy: a systematic review
por: Dervenis, Panagiotis, et al.
Publicado: (2021)

The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage
por: Li, Shengguo, et al.
Publicado: (2022)

Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: a randomized clinical trial
por: Jorge, Danilo Moyses, et al.
Publicado: (2021)

Angiogenic and Vasculogenic Factors in the Vitreous from Patients with Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Elevated vitreous Lipocalin-2 levels of patients with proliferative diabetic retinopathy
por: Wang, Hui, et al.
Publicado: (2020)

Vitreous hemorrhage in diabetes patients with proliferative diabetic retinopathy undergoing hemodialysis
por: Kameda, Yusuke, et al.
Publicado: (2019)

Correlation of Complement Activation in Aqueous and Vitreous in Patients With Proliferative Diabetic Retinopathy
por: Smith, Jesse M., et al.
Publicado: (2022)

Exosomal miRNA Profiling in Vitreous Humor in Proliferative Diabetic Retinopathy
por: Kot, Agnieszka, et al.
Publicado: (2022)

Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture
por: Malik, Deepika, et al.
Publicado: (2014)

Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
por: Shaikh, Saad
Publicado: (2008)

Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage
por: Mansour, Ahmad M., et al.
Publicado: (2020)

Tractional Retinal Detachment in Eyes with Vitreous Hemorrhage and Proliferative Diabetic Retinopathy and Posterior Vitreous Detachment in Fellow Eye
por: Joo, Chan Woong, et al.
Publicado: (2023)

Effects of bevacizumab on the neovascular membrane of proliferative diabetic retinopathy: reduction of endothelial cells and expressions of VEGF and HIF-1α
por: Han, Xiao-Xia, et al.
Publicado: (2012)

Increased Vitreous Shedding of Microparticles in Proliferative Diabetic Retinopathy Stimulates Endothelial Proliferation
por: Chahed, Sadri, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_kohdosdslshm8c7bkp23b6eh88